Glomerular expression of p27(Kip1) in diabetic db/db mouse: Role of hyperglycemia

Kidney International

Volumn 53, Issue 4, 1998, Pages 869-879

  Wolf, Gunter ^a   Schroeder, Regine ^b   Thaiss, Friedrich ^b   Ziyadeh, Fuad N ^b   Helmchen, Udo ^b   Stahl, Rolf A K ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

Cell cycle progression; Cyclin dependent kinases; Diabetic nephropathy

Indexed keywords

PROTEIN P27; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ENZYME INHIBITOR; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CULTURE MEDIUM; DIABETIC NEPHROPATHY; EXPERIMENTAL MODEL; GLOMERULUS; HYPERGLYCEMIA; IMMUNOPRECIPITATION; MESANGIUM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MESANGIUM; METABOLISM; MOUSE MUTANT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GENE EXPRESSION; GLOMERULAR MESANGIUM; HETEROZYGOTE; HOMOZYGOTE; HYPERGLYCEMIA; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROTUBULE-ASSOCIATED PROTEINS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0031596570     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00829.x     Document Type: Article

References (55)

1. CHOWDHURY TA, BARNETT AH, BAIN SC: Pathogenesis of diabetic nephropathy. Trends Endocrinol Metab 7:320-323, 1996
2. IBRAHIM HN, HOSTETTER TH: Diabetic nephropathy. J Am Soc Nephrol 8:487-493, 1947
3. PERNEGER TV, BRANCATI FL, WHELTON PK, KLAG MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121: 912-918, 1994
4. NELSON RG, BENNETT PH, BECK GJ, TAN M, KNOWLER WC, MITCH WE, HIRSCHMAN GH, MYERS BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 335:1636-1642, 1996
5. RITZ E, KELLER C, BERGIS KH: Nephropathy of type II diabetes mellitus. Nephrol Dial Transplant 11(Suppl 9):38-44, 1996
6. PAGTALUNAN ME, MILLER PL, JUMPING-EAGLE S, NELSON RG, MYERS BD, RENNKE HG, COPLON NS, SUN L, MEYER TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348, 1997
7. PORTE D, SCHWARTZ MW: Diabetes complications: Why is glucose potentially toxic? Science 272:699-700, 1996
8. BUCALA R, VLASSARA H: Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26:875-888, 1995
9. COHEN MP, ZIYADEH FN: Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 7:183-190, 1996
10. WOLF G, SHARMA K, CHEN Y, ERICKSEN M, ZIYADEH FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
11. COSIO FG: Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol 5:1600-1609, 1995
12. NAHMAN NS, LEONHARDT KL, COSIO FG, HEBERT CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41:396-402, 1992
13. ZIYADEH FN, SHARMA K, ERICSEN M, WOLF G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
14. AYO SH, RADNIK RA, GLASS WF II, GARONI JA, RAMPT ER, APPLING DR, KREISBERG JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
15. Kip1 in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Physiol 273:F348-F356, 1997
16. COHEN MP, SHARMA K, JIN Y, HUD E, WU VY, TOMASZEWSKI J, ZIYADEH FN: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J Clin Invest 95:2338-2345, 1995
17. VELASQUEZ MT, KIMMEL PL, MICHAELIS OE: Animal models of spontaneous diabetic kidney disease. FASEB J 4:2850-2859, 1990
18. LIKE AA, LAVINE RL, POFFENBARGER PI, CHICK WL: Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol 66:193-224, 1972
19. GÄRTNER K: Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (C57BL/6J db/db and C57BL/ KsJ db/db). Diabetologia 15:59-63 (1978)
20. ITAGAKI SI, NISHIDA E, LEE MJ, DOI K: Histopathology of subacute renal lesions in mice induced by streptozotocin. Exp Toxic Pathol 47:485-491, 1995
21. THAISS F, WOLF G, ASSAD N, ZAHNER G, STAHL RAK: Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats. Diabetologia 39:275-280, 1996
22. WOLF G, HABERSTROH U, NEILSON EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
23. Kip1. Kidney Int 50:2112-2119, 1996
24. Kip1 for restriction point of the fibroblast cell cycle. Science 272:877-880, 1996
25. BENNETT CF, CHIANG MY, CHAN H, SHOEMAKER JE, MIRABELLI CK: Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41:1023-1033, 1992
26. WESTBERG NG, MICHAEL AF: Immunohistopathology of diabetic glomerulosclerosis. Diabetes 21:163-174, 1972
27. KREISBERG JI, AYO SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43:109-113, 1993
28. KLEINMAN KS, FINE LG: Prognostic implications of renal hypertrophy in diabetes mellitus. Diab Metabol Rev 4:179-189, 1988
29. WOLF G, THAISS F: Hyperglycemia-pathophysiological aspects at the cellular level. Nephrol Dial Transplant 10: 1109-1112, 1995
30. MOGYORÓSI A, ZIYADEH FN: Update on pathogenesis, markers and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 5:243-253, 1996
31. YOUNG BA, JOHNSON RJ, ALPERS CE, ENG E, GORDON K, FLOEGE J, COUSER WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
32. WOLF G, ZIYADEH FN: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29:153-163, 1997
33. OKAYAMA H, NAGATA A, JINNO S, MURAKAMI H, TANAKA K, NAKASHIMA N: Cell cycle control in fission yeast and mammals: Identification of new regulatory mechanisms. Cancer Res 69:17-62, 1996
34. ELLEDGE SJ: Cell cycle checkpoints: Preventing an identiity crisis. Science 274:1664-1672, 1996
35. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382:325-331, 1996
36. 1 cyclin-dependent kinases. Genes Develop 9:1149-1163, 1995
37. GRANA X, REDDY EP: Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219, 1995
38. ROBERTS JM, KOFF A, POLYAK K, FIRPO E, COLLINS S, OHTSUBO M, MASSAGUÉ J: Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harb Symp Quant Biol 59:31-38, 1994
39. BERGLUND O, FRANKEL BJ, HELLMAN B: Development of the insulin secretory defect in genetically diabetic (db/db) mouse. Acta Endocrinol 87:543-551, 1978
40. LEE GH, PROENCA R, MONTEZ JM, CARROLI KM, DARVISHZADEH JG, LEE JI, FRIEDMAN JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996
41. CHEN H, CHARLAT O, TARTAGLIA LA, WOOLF FA, WENG X, ELLIS SJ, LAKEY ND, CULPEPPER J, MOORE KJ, BRETTBART RE, DUYK GM, TEPPER RI, MORGENSTERN JP: Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in dbldb mice. Cell 84:491-495, 1996
42. CARO JF, SINHA MK, KOLACZYNSKI JW, ZHANG PL, CONSIDINE RV: Leptin: The tale of an obesity gene. Diabetes 45:1455-1462, 1996
43. LEE SM, BRESSLER R: Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes 30:106-111, 1981
44. ZHANG B, GRAZIANO MP, DOEBBER TW, LEIBOWITZ MD, WHITE-CARRINGTON S, SZALKOWSKI DM, HEY PJ, WU M, CULLINAN CA, BAILEY P, LOLLMANN B, FREDERICH R, FLIER JS, STRADER CD, SMITH RG: Down-regulation of the expression of the obese gene by an antidiabetic thiazolinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455-9459, 1996
45. SHANKLAND SJ, HUGO C, COATS SR, NANGAKU M, PICHLER RH, GORDON KL, PIPPIN J, ROBERTS JM, COUSER WG, JOHNSON RJ: Changes in cell-cycle protein expression during experimental mesangial proliferate glomerulonephritis. Kidney Int 50:1230-1239, 1996
46. LODA M, CUKOR B, TAM SW, LAVIN P, FLORENTINO M, DRAETTA GF, JESSUP JM, PAGANO M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal cracinomas. Nature Med 3:231-234, 1997
47. KING RW, DESHAIES RJ, PETERS JM, KIRSCHNER MW: How proteolysis drives the cell cycle. Scinece 274:1652-1659, 1996
48. UDVARDY A: The role of controlled proteolysis in cell-cycle regulation. Eur J Biochem 240:307-313, 1996
49. OLBRICHT CJ, GEISSINGER B: Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes. Kidney Int 41:966-972, 1992
50. Kip1. Kidney Int 51:1088-1099, 1997
51. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720, 1996
52. 1 phase cyclin dependent kinases by transforming growth factor β1. J Cell Biochem 56:418-425, 1994
53. 1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90:10315-10319, 1993
54. 1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκBα. Immunity 5:31-40, 1996
55. EWEN ME, SLUSS HK, WHITEHOUSE LL, LIVINGSTON DM: TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 73:487-497, 1993